Global Interventional Cardiology Devices Market Research Report
- Report Code: IN 1000
- Publish Date: Upcoming
The report “Interventional Cardiology Devices Market forecast, 2008-2018” analyzes the market of devices into 8 sub markets such as EVAR Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Angioplasty Balloons, Angioplasty Stents, Interventional Cardiology Catheters, Hemodynamic Flow Alteration Devices and Interventional Cardiology Accessory Devices. Stents segment have been contributing largest in terms of value towards Interventional Cardiology Devices Market and Drug Eluting Stents have the highest market share amongst the stents. The huge share is a consequence of the popularity of DES as these reduce the possibility of restenosis.
The total Asia Pacific Interventional Cardiology Devices Market is expected to grow at a fast pace. Increased number of procedures in India and China will drive the Market, while those in Australia and South Korea are expected to remain flat.
The United States and Europe will also see flat procedural growth and declining ASPs. The north American Interventional Cardiology Devices Market is expected to have a slow growth. Various factors such as increasing peripheral intervention in the U.S., momentous increase in the number of percutaneous coronary intervention (PCI) centers in the U.S., growth in aging population, are the major drivers for the North American interventional cardiology devices market. On the other hand, declining coronary angioplasty procedures in the U.S. and conventional first level medication treatment are considered as hindrances for the growth of North American peripheral vascular devices market.
Competition and reimbursement restrictions will push average selling prices (ASP) down in all national markets.
Bioabsorbable stents and retrievable inferior vena cava filters are expected to grow at higher CAGRs. The inferior vena cava filters market growth is mainly due to increase in deep vein thrombosis at the same time the next generation stents market is also rapidly increasing due to reduced risk of restenosis.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies covered in the report are Boston Scientific Corporation, Medtronic Inc., Abbott Laboratories, W.L.Gore and Associates Inc., etc.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
The Market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- Adoption rate analysis of the products (Segment wise and Country wise)
Epidemiology Data
- Country specific Prevalence of CVD leading to Angioplasty Procedures
- Country specific Patient pool of CVD patients seeking Angioplasty treatment
Procedure Volume Data
- Plain old balloon angioplasty(POBA), Percutaneous Transluminal Coronary Angioplasty(PTCA), Percutaneous Transluminal (Peripheral) Angioplasty (PTA) procedures performed annually in each Country tracked
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
Alternative procedures like coronary artery bypass graft (CABG).
MMM’s Healthcare Decision Making Quadrant
It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 EVAR Stent Grafts
4.2 Inferior Vena Cava (IVC) Filters
4.3 Plaque Modification Devices
4.4 Angioplasty Ballons
4.5 Angioplasty Stents
4.6 Interventional Cardiology Catheters
4.7 Hemodynamic Flow Alteration Devices
4.8 Interventional Cardiology Accessory Devices
5 By SurgeryProcedures
5.1 Angioplasty Procedures
6 By Processes
6.1 Catheterization
7 By Geographies
7.1 North America
7.2 Europe
7.3 Rest of World
7.4 Asia
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
EVAR Stent Grafts EVAR is a minimally invasive alternate for the repair of abdominal aortic aneurysms.EVAR Stent grafts market can be segmented by Geographies, Product type, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Inferior Vena Cava (IVC) Filters Inferior Vena Cava (IVC) Filters and EVAR Stent Grafts, |
Upcoming |
|
|
Plaque Modification Devices Plaque Modification Devices and EVAR Stent Grafts, |
Upcoming |
|
|
Angioplasty Ballons Angioplasty Ballons and EVAR Stent Grafts, Inferior... |
Upcoming |
|
|
Angioplasty Stents Angioplasty Stents and EVAR Stent Grafts, Inferior... |
Upcoming |
|
|
Interventional Cardiology Catheters Interventional Cardiology Catheters and EVAR Stent Grafts, |
Upcoming |
|
|
Hemodynamic Flow Alteration Devices Hemodynamic Flow Alteration Devices and EVAR Stent Grafts, |
Upcoming |
|
|
Angioplasty Procedures Angioplasty Procedures can be segmented by Geographies, MacroIndicators and Types. Geographies of this market are North America, Europe, Rest of World and Asia. MacroIndicators of this market are Healthcare Expenditure. Types of this market are |
Upcoming |
|
|
Interventional Cardiology Accessory Devices Interventional Cardiology Accessory Devices and EVAR Stent Grafts, |
Upcoming |
|
|
Abdominal Aortic Stent Grafts Abdominal Aortic Stent Grafts and Thoracic Aortic Stent Grafts adds up to total |
Upcoming |
|
|
Thoracic Aortic Stent Grafts Thoracic Aortic Stent Grafts and Abdominal Aortic Stent Grafts adds up to total |
Upcoming |
|
|
Permanent IVC Filters Permanent IVC Filters and Retrievable IVC Filters adds up to total |
Upcoming |
|
|
Retrievable IVC Filters Retrievable IVC Filters and Permanent IVC Filters adds up to total |
Upcoming |
|
|
Thrombectomy Devices Thrombectomy Devices and Atherectomy Devices adds up to total |
Upcoming |
|
|
Atherectomy Devices Atherectomy Devices and Thrombectomy Devices adds up to total |
Upcoming |
|
|
Angiography Catheters Angiography Catheters and Guiding catheters, Intravascular Ultrasound Catheters and |
Upcoming |
|
|
Chronic Total Occlusion Devices Chronic Total Occlusion Devices and Embolic Protection Systems adds up to total |
Upcoming |
|
|
Plain Old Balloon Angioplasty (POBA) Plain Old Balloon Angioplasty (POBA) and Percutaneous Transluminal Coronary Angioplasty (PTCA) and |
Upcoming |
|
|
Percutaneous Transluminal Coronary Angioplasty (PTCA) Percutaneous Transluminal Coronary Angioplasty (PTCA) and Plain Old Balloon Angioplasty (POBA) and |
Upcoming |
|
|
Percutaneous Transluminal (Peripheral) Angioplasty (PTA) Percutaneous Transluminal (Peripheral) Angioplasty (PTA) and Plain Old Balloon Angioplasty (POBA) and |
Upcoming |
